Core One Labs Inc (OTCMKTS:CLABF) Stock Soars As Company Gets Positive Results from Bioassay Studies
Last Friday, the Core One Labs Inc (OTCMKTS:CLABF) stock was in the middle of a strong rally and ended up with gains of as much as 12% as a consequence. As it happens, the stock could in focus among investors today as well in light of the announcement made by the company last this past Saturday.
Market Stats
On Friday, CLABF stock soared 12% to $0.7941 with more than 10.14K shares, compared to its average volume of 31.9K shares. The stock moved within a range of $0.7300 – 0.8025 after opening trading at $0.7570.
Core One Labs’ Akome Receives Positive Results from Bioassay Studies
At the time the company announced that its fully owned subsidiary company Akome Biotech Ltd had managed to get positive results during its research arrangement with the Italy based company Neuro-Zone Srl. The study in question was a vitro biological assay into the psychedelic patent pending bioactive compounds that had been developed by Core One.
The company claims that the compounds could well prove to be ground breaking when it comes to treating Alzheimer’s disease and Parkinson’s disease among others. In addition to that, it could also be used to prevent stroke and cure depression. Hence, it is likely that the stock is going to come on to the radars of investors this morning. It may be a good move from investors at this point to add the Core One stock to their watch lists and watch the price action.
Key Quote
“The positive results from these studies have demonstrated that Akome is making significant steps towards developing groundbreaking drug formulations that can be used to treat neurological diseases. This is great news for the tens of millions of people who are affected by Alzheimer’s, Parkinson’s, Depression and Stroke, across the globe,” stated Joel Shacker, the Company’s CEO.
Traders Corner
CLABF stock is trading below the 50-Day and 200-Day Moving averages of $0.81 and $1.82 respectively. However, the stock is trading above the 20-Day moving average of $0.76.
